2nd Circuit Won’t Order Changes To MS Drug Patent License Arbitration Award
NEW YORK — A Second Circuit U.S. Court of Appeals panel on July 15 affirmed a New York federal judge’s denial of a plaintiff-appellant biopharmaceutical company’s motion to vacate or modify...To view the full article, register now.
Already a subscriber? Click here to view full article